Analysis: Will Scholz’s Visit Help BioNTech’s Covid Shot in China?
(Blue View) — Under a collaboration accord between China and Germany reached last week during German Chancellor Olaf Scholz’s visit to Beijing, BioNTech SE’s Covid-19 vaccine is to be made available to foreigners in China.
The agreement is seen as a potential first step toward offering the advanced mRNA shot more widely across the Chinese mainland. BioNTech’s China partner is Shanghai Fosun Pharmaceutical Group Co.
- MOST POPULAR